Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter.

The company runs a capital-efficient, high-return business centered around the established and stable North American water ...

The company stands out as a strong example of setting bold objectives, meeting them, and delivering long-term value to its ...

On June 4, the company declared a quarterly dividend of $1.50 per share, having raised it by 5.6% in March. This marked the ...

The company holds one of the longest dividend streaks in the industry, spanning 68 years, which makes it a reliable ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

Viatris Inc. (NASDAQ: VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval ...

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in ...